BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14654921)

  • 1. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
    Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
    Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma.
    Tachimori A; Yamada N; Amano R; Ohira M; Hirakawa K
    Anticancer Res; 2008; 28(2A):629-38. PubMed ID: 18507001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined treatment with fluorinated pyrimidines and selective cyclooxygenase-2 inhibitors for liver metastasis of colon cancer].
    Matsunaga N; Yamada N; Hirakawa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():487-9. PubMed ID: 14574941
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
    Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
    Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
    Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.
    Liu ES; Shin VY; Ye YN; Luo JC; Wu WK; Cho CH
    Eur J Pharmacol; 2005 Jul; 518(1):47-55. PubMed ID: 15993407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
    Chen WS; Wei SJ; Liu JM; Hsiao M; Kou-Lin J; Yang WK
    Int J Cancer; 2001 Mar; 91(6):894-9. PubMed ID: 11275997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
    Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
    J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
    Smakman N; Kranenburg O; Vogten JM; Bloemendaal AL; van Diest P; Borel Rinkes IH
    Clin Cancer Res; 2005 Jan; 11(1):41-8. PubMed ID: 15671526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
    Kundu N; Fulton AM
    Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis.
    Kakiuchi Y; Tsuji S; Tsujii M; Murata H; Kawai N; Yasumaru M; Kimura A; Komori M; Irie T; Miyoshi E; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2002 Mar; 62(5):1567-72. PubMed ID: 11888937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin.
    Yazawa K; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Asakage M; Sunami E; Kaisaki S; Hori N; Watanabe T; Takahashi K; Nagawa H
    Cancer Sci; 2005 Feb; 96(2):93-9. PubMed ID: 15723653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.